Michael Morris

57PUBLICATIONS

376CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMolecular targetsHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (57)

Sort by Publication Date:

|Jul 09, 2026

Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.

|Mar 18, 2026

Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer.

Jeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack

|Feb 26, 2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 02, 2026

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.

Salomon Tendler, Roberto De Gregorio, Paul Balderes

|Jan 27, 2026

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169.

Samir Zaidi, Phillip H Kuo, Tiago Paiva Prudente

|Jan 26, 2026

Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial.

José C Valentín López, Chenxi Yu, Todd P Knutson

Pageof 10

Frequent Collaborators

14 joint publications

Andrew J Armstrong

13 joint publications

Susan Halabi

10 joint publications

Himisha Beltran

Wassim Abida

Scott Tagawa

Oliver Sartor

David B Solit

Alan H Bryce

Konrad H Stopsack

Maha Hussain

Frequent Collaborators

14 joint publications

Andrew J Armstrong

13 joint publications

Susan Halabi

10 joint publications

Himisha Beltran

7 joint publications

Wassim Abida